Overview

• Regulators granted the first clearance for an app-plus-CGM system specifically for weight management, establishing a new non-drug option in the category.
• Signos integrates Dexcom’s Stelo sensor with an AI app that analyzes real-time glucose to deliver individualized recommendations and weight targets.
• Consumers can buy subscriptions without a prescription, with three- or six-month plans priced about $139 and $129 per month and sensors shipped for the full term.
• Health insurers are not covering the service at launch, and Signos says it is in discussions with plans and employers to pursue reimbursement.
• The company says the system can complement GLP-1 medications or bariatric surgery and helps users understand responses to food, activity, sleep and stress.